Mezigdomide Regimen Promising for Relapsed/Refractory Myeloma
Mezigdomide plus Velcade and dexamethasone or Kyprolis and dexamethasone showed promising response rates across multiple doses in patients with relapsed or refractory multiple myeloma, research showed.